Abstract
Thirty-nine adult patients with human immunodeficiency virus infection and oral candidiasis were randomly assigned to receive either one fluconazole capsule (100 mg) or five clotrimazole troches (10 mg each) daily for 14 days. Among 36 evaluable patients, clinical resolution rates were 100 and 65%, respectively (P = 0.018). Mycological eradication rates were 75 and 20%, respectively (P = 0.004). Fluconazole-treated patients were more likely to remain disease free during follow-up than those treated with clotrimazole (P = 0.014 at 2 weeks). Prolonged clinical responses correlated with mycological eradication at the end of therapy (P = 0.043).
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Chave J. P., Cajot A., Bille J., Glauser M. P. Single-dose therapy for oral candidiasis with fluconazole in HIV-infected adults: a pilot study. J Infect Dis. 1989 Apr;159(4):806–807. doi: 10.1093/infdis/159.4.806. [DOI] [PubMed] [Google Scholar]
- De Wit S., Weerts D., Goossens H., Clumeck N. Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS. Lancet. 1989 Apr 8;1(8641):746–748. doi: 10.1016/s0140-6736(89)92572-5. [DOI] [PubMed] [Google Scholar]
- Nathwani D., Green S. T., McGuire W., Goldberg D. J., Kennedy D. H. New triazole antifungal agents (fluconazole and itraconazole) in the treatment of HIV-related gastrointestinal candidiasis. Scand J Infect Dis. 1989;21(3):355–356. doi: 10.3109/00365548909035712. [DOI] [PubMed] [Google Scholar]
- Rinaldi M. G. Use of potato flakes agar in clinical mycology. J Clin Microbiol. 1982 Jun;15(6):1159–1160. doi: 10.1128/jcm.15.6.1159-1160.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Saag M. S., Dismukes W. E. Azole antifungal agents: emphasis on new triazoles. Antimicrob Agents Chemother. 1988 Jan;32(1):1–8. doi: 10.1128/aac.32.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]